Continuity and digitization of the pharmaceutical industry is the direction of industrial reform promoted by the drug regulatory authorities of various countries,including the US FDA,European EMA,and China’s NMPA.After more than 20 years of development,drug 3D printing technology has become a digital preparation technology that drives the”paradigm transition”of the pharmaceutical industry.As a global leader in the field of 3D printing drugs,Triassic has achieved a breakthrough in the core technology MED(Melt Extrusion Deposition)through unremitting innovation,providing end-to-end technical solutions for the long-term pharmaceutical chain.However,it is not easy to move from R&D equipment to industrialization and realize a continuous 3D printing drug production line with an annual production capacity of 50 million pieces.A careful industrialization plan is an important foundation for achieving breakthroughs in throughput production technology.
制药产业的连续化和数字化是包括美国FDA、欧洲EMA和中国NMPA在内的各国药品监督管理部门所推进的产业改革方向。药物3D打印技术历经20多年发展,已成为驱动制药产业“范式跃迁”的数字化制剂技术。作为全球3D打印药物领域的引领者,三迭纪经过不懈创新实现了核心技术MED(Melt Extrusion Deposition,热熔挤出沉积)的突破,为制药长链条提供端到端的技术解决方案。但想要从研发型设备迈向产业化,实现年产能达5,000万片的3D打印药物连续化生产线并非易事,缜密的产业化规划是实现通量生产技术突破的重要基础。
GE GENERAL ELECTRIC BUS PLUG SB364RGR 200A 3W 600V GRND
CH Cutler Hammer Circuit Breaker HKD3400 3P 400A 65K
GE GENERAL ELECTRIC BUS PLUG SB364R 200A 3W 600V SB
GE GENERAL ELECTRIC BUS PLUG SB364RG 200A 3W 600V GRND
JGL26250 Square D Circuit Breaker 250A 2P JGF26250
GE GENERAL ELECTRIC BUS PLUG SB324R 200A 3W 240V SB
GENERAL ELECTRIC Circuit Breaker Trip TKMA3T1200 1200A
SQUARE D Circuit Breaker KC34200 KC342001021 200A ILine